Zissimopoulos A - Search Results

1

Association between bone scintigraphy and serum levels of procollagen (I) and PSA in the detection of bone disease in prostate cancer patients.

Zissimopoulos A, Bantis A, Stellos K, Petrakis G, Matthaios D. Zissimopoulos A, et al. J BUON. 2008 Jan-Mar;13(1):69-74. J BUON. 2008. PMID: 18404790

2

Strontium-89 chloride in the treatment of bone metastases from breast cancer.

Baziotis N, Yakoumakis E, Zissimopoulos A, Geronicola-Trapali X, Malamitsi J, Proukakis C. Baziotis N, et al. Among authors: zissimopoulos a. Oncology. 1998 Sep-Oct;55(5):377-81. doi: 10.1159/000011881. Oncology. 1998. PMID: 9732212 Clinical Trial.

3

[The importance of the tumor marker CYFRA 21-1 in patients with lung cancer after surgery or chemotherapy].

Zissimopoulos A, Stellos K, Permenopoulou V, Petrakis G, Theodorakopoulos P, Baziotis N, Thalassinos N. Zissimopoulos A, et al. Hell J Nucl Med. 2007 Jan-Apr;10(1):62-6. Hell J Nucl Med. 2007. PMID: 17450257 Clinical Trial. Greek, Modern.

4

Association between bone scintigraphy and serum levels of tumor markers in the detection of bone disease in breast cancer patients.

Zissimopoulos A, Matthaios D, Matthaiou E, Mantadakis E, Karaitianos I. Zissimopoulos A, et al. J BUON. 2007 Oct-Dec;12(4):505-11. J BUON. 2007. PMID: 18067209

5

Four prognostic indices in advanced prostate cancer patients, under palliative androgen deprivation treatment.

Bantis A, Zissimopoulos A, Kalaitzis C, Giannakopoulos S, Sountoulides P, Parmenopoulou V, Agelonidou E, Touloupidis S. Bantis A, et al. Among authors: zissimopoulos a. Hell J Nucl Med. 2008 Jan-Apr;11(1):21-5. Hell J Nucl Med. 2008. PMID: 18392222

6

Type I collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy.

Zissimopoulos A, Stellos K, Matthaios D, Petrakis G, Parmenopoulou V, Babatsikou F, Matthaiou E, Theodosiadou E, Hountis P, Koutis C. Zissimopoulos A, et al. J BUON. 2009 Jul-Sep;14(3):463-72. J BUON. 2009. PMID: 19810140

7

The prognostic value of serum chromogranin A and prostate specific antigen in prostate cancer patients for progression to the hormone resistance state.

Zissimopoulos A, Bantis A, Sountoulides P, Giannakopoulos S, Kalaitzis C, Agelonidou E, Touloupidis S. Zissimopoulos A, et al. Hell J Nucl Med. 2009 Sep-Dec;12(3):234-7. Hell J Nucl Med. 2009. PMID: 19936334

8

Tissue polypeptide antigen in the follow-up of patients with urinary bladder cancer compared with conventional urine cytology.

Bantis A, Zissimopoulos A, Sountoulides P, Giannakopoulos S, Kalaitzis C, Athanassiadou P, Agelonidou E, Touloupidis S. Bantis A, et al. Among authors: zissimopoulos a. Hell J Nucl Med. 2010 Sep-Dec;13(3):213-7. Hell J Nucl Med. 2010. PMID: 21193872

9

Minimal invasive treatment options in pregnant women with ovarian vein syndrome.

Kalaitzis C, Zissimopoulos A, Bantis A, Giannakopoulos S, Galazios G, Limperis V, Touloupidis S. Kalaitzis C, et al. Among authors: zissimopoulos a. Arch Gynecol Obstet. 2012 Jan;285(1):83-5. doi: 10.1007/s00404-011-1926-6. Epub 2011 May 27. Arch Gynecol Obstet. 2012. PMID: 21617922

10

Bisphosphonate-induced osteonecrosis of the jaw in patients with bone metastatic, hormone-sensitive prostate cancer. Risk factors and prevention strategies.

Bantis A, Zissimopoulos A, Sountoulides P, Kalaitzis C, Giannakopoulos S, Deftereos S, Tsakaldimis G, Thomaidis V, Touloupidis S. Bantis A, et al. Among authors: zissimopoulos a. Tumori. 2011 Jul-Aug;97(4):479-83. doi: 10.1177/030089161109700411. Tumori. 2011. PMID: 21989437

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters